Reduction of “Rebound” Hypercoagulability by Gradual Withdrawal (“Tailing Off”) of Oral Anticoagulants

Poller, L.; Thomson, Jean M.
June 1965
British Medical Journal;6/5/1965, Vol. 1 Issue 5448, p1475
Academic Journal
No abstract available.


Related Articles

  • Should We Perform Serial Ultrasonography to Tailor Anticoagulation Therapy for Patients with DVT? Varon, Joseph // Internal Medicine Alert;6/29/2009, Vol. 31 Issue 12, p93 

    In patients with proximal deep vein thrombosis (DVT), tailoring the duration of oral anticoagulation based on serial ultrasonography reduces the rate of recurrent DVT. Prolongation of chronic anticoagulation may accelerate vein recanalization. Residual DVT on ultrasonography is a marker of...

  • THROMBOPROPHYLAXIS IN ORTHOPAEDICS. THACHIL, J. // Kerala Journal of Orthopaedics;Jan-Jun2016/Jul-Dec2016, Vol. 29 Issue 1/2, p31 

    The article focuses on the study related to the use of thromboprophylaxis technique for treatment of venous thromboembolism (VTE) complications during orthopaedic surgery. Topics discussed include several reasons for clotting including stasis, hypercoagulability and endothelial damage; use of...

  • Recurrent intraventricular thrombus six months after ST-elevation myocardial infarction in a diabetic man: a case report. Lacalzada, Juan; Marí, Belén; Izquierdo, María Manuela; Sánchez-Grande, Alejandro; De la Rosa, Alejandro; Laynez, Ignacio // BMC Research Notes;2013, Vol. 6 Issue 1, p1 

    Background: Percutaneous coronary intervention with placement of a drug-eluting stent in a diabetic patient with ST-elevation myocardial infarction is a relatively common procedure, and always requires subsequent treatment with dual antiplatelet therapy. It is sometimes necessary to add oral...

  • Cerebral Vein Thrombosis and Lupus Anticoagulant Antibodies. Marietta, Marco; Bertesi, Marcello; Simoni, Luisa; Castelli, Ilaria; Cappi, Cinzia; Torelli, Giuseppe // Clinical & Applied Thrombosis/Hemostasis;Jul2001, Vol. 7 Issue 3, p238 

    A letter to the editor is presented regarding a case of an atypical relapse of venous thromboembolism after withdrawal of oral anticoagulant therapy in a young woman carrying an antiphospholipid antibodies syndrome.

  • Management of anticoagulants during pregnancy. Hanania, Guy // Heart;Aug2001, Vol. 86 Issue 2, p125 

    Although pregnancy induces a state of hypercoagulability, the thromoboembolic risks during a normal pregnancy are minor. This is not the case when the pregnant women has a native valvulopathy in atrial fibrillation, a mechanical prosthesis or a coagulation anomaly. The respective indications for...

  • How to prevent angina rebound when nitrate patches are withdrawn.  // Geriatrics;Dec94, Vol. 49 Issue 12, p58 

    Summarizes M. Ferratini's `Risk of Rebound Phenomenon During Nitrate Withdrawal,' published in the `International Journal of Cardiology' in 1994. Reduction of angina rebound through the administration of low-nitrate treatment.

  • Warfarinem indukovaná nekróza kůže. CHLUMSKÝ, J.; HAVLÍN, J. // General Practitioner / Prakticky Lekar;2013, Vol. 93 Issue 5, p231 

    Skin necrosis is a rare but serious complication of oral anticoagulant therapy with warfarin. It is caused by extensive thrombosis of postcapillary venules in the subcutaneous fat, most often in individuals with thrombophilia. Pathogenesis of necrosis is explained by an imbalance of coagulation...

  • Anticoagulants.  // Reactions Weekly;7/7/2007, Issue 1159, p6 

    The article describes the case of a two elderly men who developed pulmonary hematoma during treatment with oral anticoagulants. An overview of the clinical history of the patients is presented. Management of the condition is discussed, which include the withdrawal of oral anticoagulants. Patient...

  • Generalized Pustular Psoriasis on Withdrawal of Clobetasol Propionate Ointment. Boxley, J.D.; Dawber, R.P.R.; Summerly, R. // British Medical Journal;5/3/1975, Vol. 2 Issue 5965, p255 

    Examines the treatment of generalized pustular psoriasis from chronic psoriasis in Great Britain. Efficacy of withdrawal of systemic corticosteroid treatment; Occurrence of rebound effect on reduction or withdrawal of use; Application of clobetasol propionate ointment.

  • A Head-to-Head Comparison of Periprocedural Coagulability Under Anticoagulation with Rivaroxaban Versus Dabigatran in Patients Undergoing Ablation of Atrial Fibrillation. Sairaku, Akinori; Yoshida, Yukihiko; Ando, Monami; Hirayama, Haruo; Nakano, Yukiko; Kihara, Yasuki // Clinical Drug Investigation;Nov2013, Vol. 33 Issue 11, p847 

    Background and Objectives: Two new oral anticoagulants, rivaroxaban and dabigatran, with no need for anticoagulation monitoring, are available for patients with atrial fibrillation (AF). We aimed to compare their anticoagulant effects and safety when used during the AF ablation periprocedural...


Other Topics